⌘K
Loading ticker…
As of 2026-08-24, AXIL Brands, Inc. (AXIL) has a 3-month relative strength percentile of 31 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.4%, relative volume 6.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AXIL is in a stage 1 base, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 5.9% / -0.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
AXIL is held by 2 ETFs as of Apr 2026. Top owner: DFAC at 0.00% weight, $14K notional.
Held by 5 ETFs · $492K across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $14K | — |
| DFSU | 0.00% | $9K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AXIL Jan avg: 29.32% median: 29.32% win: 50% σ: 43.91% n: 2 2024-02-15 → 2026-07-31 | AXIL Feb avg: 10.21% median: -0.22% win: 33% σ: 18.68% n: 3 2024-02-15 → 2026-07-31 | AXIL Mar avg: -12.26% median: -1.09% win: 33% σ: 22.99% n: 3 2024-02-15 → 2026-07-31 | AXIL Apr avg: 2.30% median: -3.71% win: 33% σ: 19.21% n: 3 2024-02-15 → 2026-07-31 | AXIL May avg: -7.55% median: -0.65% win: 0% σ: 12.13% n: 3 2024-02-15 → 2026-07-31 | AXIL Jun avg: -7.72% median: -10.73% win: 0% σ: 6.60% n: 3 2024-02-15 → 2026-07-31 | AXIL Jul avg: 9.30% median: -10.60% win: 33% σ: 45.01% n: 3 2024-02-15 → 2026-07-31 | AXIL Aug avg: -23.25% median: -23.25% win: 0% σ: 18.52% n: 2 2024-02-15 → 2026-07-31 (current) | AXIL Sep avg: -3.46% median: -3.46% win: 50% σ: 22.00% n: 2 2024-02-15 → 2026-07-31 | AXIL Oct avg: -5.63% median: -5.63% win: 0% σ: 7.97% n: 2 2024-02-15 → 2026-07-31 | AXIL Nov avg: -5.04% median: -5.04% win: 0% σ: 5.16% n: 2 2024-02-15 → 2026-07-31 | AXIL Dec avg: 13.41% median: 13.41% win: 50% σ: 31.64% n: 2 2024-02-15 → 2026-07-31 |